Clinical Features of Severe Dementia: Staging

Severe Dementia

Volumn , Issue , 2006, Pages 83-115

  Reisberg, Barry ^a   Wegiel, Jerzy ^b   Franssen, Emile ^a   Kadiyala, Sridhar ^a   Auer, Stefanie ^c   Souren, Liduïn ^a   Sabbagh, Marwan ^d   Golomb, James ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^c Morbus Alzheimer's Society   (Australia)

^d SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Clinical dementia rating (CDR); FAST staging procedure; Global deterioration scale (GDS) and functional assessment staging (FAST) system (GDS FAST); Severe dementia phase; Stages of severe dementia

Indexed keywords

EID: 84885762502     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470010568.ch8     Document Type: Chapter

References (54)

1. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P (2003) Prevalence and characteristics of dementia in Parkinson's disease. Archives of Neurology, 60:387-392.
2. Auer SR, Sclan SG, Yaffee RA, Reisberg B (1994) The neglected half of Alzheimer disease: cognitive and functional concomitants of severe dementia. Journal of the American Geriatrics Society, 42:1266-1272.
3. Berg L (1988) Clinical dementia rating (CDR). Psychopharmacology Bulletin, 24:637-639.
4. Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and senile change in the cerebral gray matter of elderly subjects. British Journal of Psychiatry, 114:797-811.
5. Bobinski M, Wegiel J, Wisniewski HM, Tarnawski M, Reisberg B, Mlodzik B, de Leon MJ, Miller DC (1995) Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. Dementia, 6:205-210.
6. Bobinski M, Wegiel J, Tarnawski M, Reisberg B, de Leon MJ, Miller DC, Wisniewski HM (1997) Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 56:414-420.
7. Capute AJ, Shapiro BK, Accardo PJ, Wachtel RL, Ross A, Palmer FB (1982) Motor functions: associated primitive reflex profiles. Developmental Medicine and Child Neurology, 24:662-669.
8. Cummings JL (1988) The dementias of Parkinson's disease: prevalence, characteristics, neurobiology, and comparison with dementia of the Alzheimer's type. European Journal of Neurology, 28:15-23.
9. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12:189-198.
10. Franssen EH (1993) Neurologic signs in ageing and dementia, In: Burns, A. and Levy, R., eds., Aging and Dementia, A Methodological Approach. London: Edward Arnold, 144-174.
11. Franssen EH, Reisberg B (1997) Neurologic markers of the progression of Alzheimer disease. International Psychogeriatrics, 9:297-306.
12. Franssen EH, Reisberg B, Kluger A, Sinaiko E, Boja C (1991) Cognition-independent neurologic symptoms in normal aging and probable Alzheimer's disease. Archives of Neurology, 48:148-154.
13. Franssen EH, Kluger A, Torossian CL, Reisberg B (1993) The neurologic syndrome of severe Alzheimer's disease: relationship to functional decline. Archives of Neurology, 50:1029-1039.
14. Franssen EH, Souren LEM, Torossian CL, Reisberg B (1997) Utility of developmental reflexes in the differential diagnosis and prognosis of incontinence in Alzheimer disease. Journal of Geriatric Psychiatry and Neurology, 10:22-28.
15. Franssen EH, Souren LEM, Torossian CL, Reisberg B (1999) Equilibrium and limb coordination in mild cognitive impairment and mild Alzheimer's disease. Journal of the American Geriatrics Society, 47:463-499.
16. Giladi N, Treves TA, Paleacu D, Shabtai H, Orlov Y, Kandinov B, Simon ES, Korczyn AD (2000) Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. Journal of Neural Transmission, 107:59-71.
17. Golomb J, WisoffJ, Miller DC, Kluger A, Weiner H, Salton J, Graves W (2000) Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response. Journal of Neurology, Neurosurgery, and Psychiatry, 68:778-781.
18. Hoehn MM, Yahr MD (1997) Unified Parkinson's disease rating scale [UPDRS]: modified Hoehn and Yahr staging (1967), In: Herndon, R.M., ed., Handbook of Clinical Neurologic Scales. New York: Dernos Vermande, 81-91.
19. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140:566-572.
20. Kluger A, Gianutsos JG, Golomb J, Ferris SH, George AE, Franssen EH, Reisberg B (1997) Patterns of motor impairment in normal aging, mild cognitive decline, and early Alzheimer's disease. Journal of Gerontology: Psychological Sciences, 52B:P28-P39.
21. Kluger A, Ferris SH, Golomb J, Mittelman MS, Reisberg B (1999) Neuropsychological prediction of decline to dementia in nondemented elderly. Journal of Geriatric Psychiatry and Neurology, 12:168-179.
22. Levy G, Schupf N, Ming-Xin T, Cote LJ, Louis ED, Mejia H, Stern Y, Marder K (2002) Combined effect of age and severity on the risk of dementia in Parkinson's disease. Annals of Neurology, 51:722-729.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health & Human Services Task Force on Alzheimer's disease. Neurology, 34:939-944.
24. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43:2412-2414.
25. Namenda™ Tablets, 2005. In: Physician's Desk Reference 2005. 59th edn. Montvale: Thomson Healthcare.
26. Panisset M, Roudier M, Saxton J, Boller F (1994) Severe Impairment Battery: a neuropsychological test for severely demented patients. Archives of Neurology, 51:41-45.
27. Peiper A (1963) Cerebral function in infancy and childhood. In: Wortis, J., ed., The International Behavioral Sciences Series. New York: Consultants Bureau, 147-210.
28. Reisberg B (1986) Dementia: a systematic approach to identifying reversible causes. Geriatrics, 41(4):30-46.
29. Reisberg B (1988) Functional assessment staging (FAST). Psychopharmacology Bulletin, 24:653-659.
30. Reisberg B, Ferris SH (1988) The Brief Cognitive Rating Scale (BCRS). Psychopharmacology Bulletin, 24:629-636.
31. Reisberg B, Saeed MU (2004) Alzheimer's diseas. In: Sadovoy J, Jarvik LF, Grossberg GT, Meyers BS, eds. Comprehensive Textbook of Geriatric Psychiatry, 3rd edn. New York: W.W. Norton, 449-509.
32. Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139:1136-1139.
33. Reisberg B, Schneck MK, Ferris SH, Schwartz GE, de Leon MJ (1983) The brief cognitive rating scale (BCRS): findings in primary degenerative dementia (PDD). Psychopharmacology Bulletin, 19:47-50.
34. Reisberg B, Ferris SH, Anand R, de Leon MJ, Schneck MK, Buttinger C, Borenstein J (1984) Functional staging of dementia of the Alzheimer's type. Annals of the New York Academy of Sciences, 435:481-483.
35. Reisberg B, Ferris SH, Anand R, de Leon MJ, Schneck MK, Crook T (1985a) Clinical assessment of cognitive decline in normal aging and primary degenerative dementia: concordant ordinal measures. In: Pinchot, P., Berner, P., Wolf, R., and Thau, K., eds. Psychiatry (Vol. 5). New York: Plenum Press, 333-338.
36. Reisberg B, Ferris SH, de Leon MJ (1985b) Senile dementia of the Alzheimer type: diagnostic and differential diagnostic features with special reference to functional assessment staging. In: Traber J, Gispen WH, eds. Senile Dementia of the Alzheimer Type (Vol. 2). Berlin: Springer-Verlag, 18-37.
37. Reisberg B, Ferris SH, de Leon MJ, Kluger A, Franssen EH, Borenstein J, Alba R (1989a) The stage specific temporal course of Alzheimer's disease: functional and behavioral concomitants based upon cross-sectional and longitudinal observation. In: Iqbal, K., Wisniewski, H.M., and Winblad, B., eds. Alzheimer's Disease Clinical Features: Staging 115 and Related Disorders: Progress in Clinical and Biological Research (Vol. 317). New York: Alan R. Liss, 23-41.
38. Reisberg B, Franssen EH, Sclan SG, Kluger A, Ferris SH (1989b) Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer's disease: a study of 120 patients using the BEHAVEAD. Bulletin of Clinical Neurosciences, 54:95-112.
39. Reisberg B, Ferris SH, Torossian CL, Kluger A, Monteiro I (1992) Pharmacologic treatment of Alzheimer's disease: a methodologic critique based upon current knowledge of symptomatology and relevance for drug trials. International Psychogeriatrics, 4:9-42.
40. Reisberg B, Sclan SG, Franssen EH, de Leon MJ, Kluger A, Torossian CL, Shulman E, Steinberg G, Monteiro I, McRae T, Boksay I, Mackell JA, Ferris SH (1993) Clinical stages of normal aging and Alzheimer's disease: the GDS staging system. Neuroscience Research Communications, 13:551-554.
41. Reisberg B, Sclan SG, Franssen EH, Kluger A, Ferris SH (1994) Dementia staging in chronic care populations. Alzheimer's Disease and Associated Disorders,, 8:S188-S205.
42. Reisberg B, Ferris SH, Franssen EH, Shulman E, Monteiro I, Sclan SG, Steinberg G, Kluger A, Torossian CL, de Leon MJ, Laska E (1996) Mortality and temporal course of probable Alzheimer's disease: a five-year prospective study. International Psychogeriatrics, 8:291-311.
43. Reisberg B, Auer SR, Monteiro I, Franssen E, Kenowsky S (1998) A rational psychological approach to the treatment of behavioral disturbances and symptomatology in Alzheimer's disease (AD) based upon recognition of the developmental age (DA). International Academy for Biomedical and Drug Research, 13:102-109.
44. Reisberg B, Franssen EH, Hasan SM, Monteiro I, Boksay I, Souren LEM, Kenowsky S, Auer LM, Elahi S, Kluger A (1999) Retrogenesis: clinical, physiologic and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes. European Archives of Psychiatry and Clinical Neuroscience, 249:28-36.
45. Reisberg B, Franssen EH, Souren LEM, Auer SR, Akram I, Kenowsky S (2002) Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: management and treatment import. American Journal of Alzheimer's Disease, 17:202-212.
46. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Mobius HJ (2003) Memantine in moderate to severe Alzheimer's disease. New England Journal of Medicine, 348:1333-1341.
47. Rockwood K, Howard K, Thomas VS, Mallery L, MacKnight C, Sangalang V, Darvish S (1998) Retrospective diagnosis of dementia using an informant interview based on the Brief Cognitive Rating Scale. International Psychogeriatrics, 10:53-60.
48. Sabbagh MN, Silverberg N, Bircea S, Majeed B, Samant S, Caviness JN, Reisberg B, Adler CH (2005) Is the functional decline in Parkinson's disease similar to the functional decline of Alzheimer's disease? Parkinsonism and Related Disorders, 11:311-315.
49. Sclan SG, Reisberg B (1992) Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity and ordinality. International Psychogeriatrics, 4:55-69.
50. Shimada M, Hayat J, Meguro K, Oo T, Jafri S, Yamadori A, Franssen EH, Reisberg B (2003) Correlation between functional assessment staging and the 'Basic Age' by the Binet scale supports the retrogenesis model of Alzheimer's disease: a preliminary study. Psychogeriatrics, 3:82-87.
51. Souren LEM, Franssen EM, Reisberg B (1995) Contractures and loss of function in patients with Alzheimer's disease. Journal of the American Geriatrics Society, 43:650-655.
52. Souren LEM, Franssen EH, Reisberg B (1997) Neuromotor changes in Alzheimer's disease: implications for patient care. Journal of Geriatric Psychiatry and Neurology, 10:93-98.
53. Tariot PN, Farlow M, Grossberg GT, Graham SM, McDonald S, Gergel I (2004) Memantine treatment in patients with moderate to severe Alzheimer Disease already receiving donepezil. Journal of the American Medical Association, 3:317-324.
54. Winblad B, Poritis N (1999) Memantine in severe dementia: results of the M-BEST Study (Benefit and efficacy in severely demented patients during treatment with memantine). International Journal of Geriatric Psychiatry, 14:135-146.